BioSpace News Archive

The Leukemia & Lymphoma Society named five new members to its board of directors effective July 1, 2024, whose diverse experience and interests will be instrumental in helping the organization carry out its mission to cure blood cancer and improve the quality of life of all patients and their families.

Enzolytics, Inc. (OTC PINK:ENZC) (“enzolytics.com”) (the “Company”) announced today that the Company is entering into a worldwide exclusive licensing agreement for US Patent # 8067531-B2, “Inactivated pepsin fragments for modulating immune system activity against human malignant tumor cells,” applying Immunotherapy Treatment to the global fight against cancer.

Paradromics Inc., a leading developer of brain-computer interfaces (BCI), today announced its acceptance into the U.S. Food and Drug Administration’s newest program for innovative devices, the Total Product Life Cycle Advisory Program.

Partillion Bioscience Corporation, a life science tools company, announced the commercial availability of its portfolio of single-cell analysis products in Japan.

The American Academy of Orthopaedic Surgeons (AAOS) issued a new Clinical Practice Guideline (CPG) for the Management of Acute Isolated Meniscal Pathology, which was created to help the orthopaedic community treat patients suspected of or diagnosed with an acute isolated meniscal tear.